Epidemiology of invasive pneumococcal and meningococcal disease in southeastern Ontario? Is universal infant immunization cost-effective?

被引：0
|
作者：
Simpson, CDA [1 ]
Onyett, H [1 ]
机构：
[1] Queens Univ, Kingston, ON K7L 3N6, Canada
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1754
引用
收藏
页码：307A / 307A
页数：1
相关论文
共 44 条
  • [31] Prevention of group B streptococcal disease in the first 3 months of life: Would routine maternal immunization during pregnancy be cost-effective?
    Oster, Gerry
    Edelsberg, John
    Hennegan, Kahn
    Lewin, Clement
    Narasimhan, Vas
    Slobod, Karen
    Edwards, Morven S.
    Baker, Carol J.
    VACCINE, 2014, 32 (37) : 4778 - 4785
  • [32] Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study
    Nasreen, Sharifa
    Wang, Jun
    Kwong, Jeffrey C.
    Crowcroft, Natasha S.
    Sadarangani, Manish
    Wilson, Sarah E.
    McGeer, Allison
    Kellner, James D.
    Quach, Caroline
    Morris, Shaun K.
    Sander, Beate
    Kus, Julianne, V
    Naus, Monika
    Hoang, Linda
    Rudzicz, Frank
    Fadel, Shaza
    Marra, Fawziah
    VACCINE, 2021, 39 (52) : 7545 - 7553
  • [33] Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease
    Beck, Ekkehard
    Klint, Johan
    Neine, Mohamed
    Garcia, Stephanie
    Meszaros, Kinga
    VALUE IN HEALTH, 2021, 24 (01) : 91 - 104
  • [34] COST-UTILITY ANALYSIS OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE IMMUNIZATION OF CHILDREN UNDER FIVE YEARS FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE AND PNEUMONIA IN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM
    Alexandre, R. F.
    Almeida, P.
    Sebastiao, M.
    Ferreira, P.
    Senna, T.
    VALUE IN HEALTH, 2023, 26 (06) : S77 - S77
  • [35] Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: Data for designing a cost-effective elimination policy in Spain
    Crespo, Javier
    Cuadrado, Antonio
    Perello, Christie
    Cabezas, Joaquin
    Llerena, Susana
    Llorca, Javier
    Cedillo, Sergio
    Llop, Elba
    Escudero, Maria Desamparados
    Conde, Marta Hernandez
    Puchades, Laura
    Redondo, Carlos
    Fortea, Jose I.
    de Miguel, Angel Gil
    Serra, Miguel A.
    Lazarus, Jeffrey V.
    Calleja, Jose Luis
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (04) : 360 - 370
  • [36] Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
    Scholz, Stefan
    Schwarz, Magdalena
    Beck, Ekkehard
    Meszaros, Kinga
    Schneider, Melanie
    Ultsch, Bernhard
    Greiner, Wolfgang
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 367 - 387
  • [37] Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
    Stefan Scholz
    Magdalena Schwarz
    Ekkehard Beck
    Kinga Meszaros
    Melanie Schneider
    Bernhard Ultsch
    Wolfgang Greiner
    Infectious Diseases and Therapy, 2022, 11 : 367 - 387
  • [38] COST-EFFECTIVE PRIMARY PREVENTION OF CORONARY HEART DISEASE IN INTERMEDIATE RISK PATIENTS: UNIVERSAL ASPIRIN AND STATINS IS SUPERIOR TO PREVENTION GUIDED BY STRESS TESTING
    Galper, Benjamin Z.
    Moran, Andrew
    Pletcher, Mark J.
    Coxson, Pamela
    Lazar, Lawrwence
    Wang, Y. Claire
    Heidenreich, Paul
    Goldman, Lee
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [39] Correction to: Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease
    Stefan Scholz
    Magdalena Schwarz
    Ekkehard Beck
    Kinga Meszaros
    Melanie Schneider
    Bernhard Ultsch
    Wolfgang Greiner
    Infectious Diseases and Therapy, 2022, 11 : 1311 - 1311
  • [40] Historical Population-Level Impact of Infant 13-Valent Pneumococcal Conjugate Vaccine (PCV13) National Immunization Programs on Invasive Pneumococcal Disease in Australia, Canada, England and Wales, Israel, and the United States
    Johnna Perdrizet
    Emily K. Horn
    Kyla Hayford
    Lindsay Grant
    Rachid Barry
    Liping Huang
    Cheryl McDade
    Michele Wilson
    Infectious Diseases and Therapy, 2023, 12 : 1351 - 1364
12345